Impact of nivolumab vs standard, single-agent therapy of investigator’s choice on patient-reported outcomes in recurrent or metastatic squamous cell carcinoma of the head and neck: health-related quality-of-life results from CheckMate 141, a randomized, phase 3 trial

BACKGROUND: Patients with platinum-refractory recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) have limited treatment options and poor prognosis. Nivolumab significantly improved survival of this patient population when compared with standard single-agent therapy of...

全面介紹

Na minha lista:
書目詳細資料
發表在:Lancet Oncol
Main Authors: Harrington, Kevin J, Ferris, Robert L, Blumenschein, George, Colevas, A Dimitrios, Fayette, Jerome, Licitra, Lisa, Kasper, Stefan, Even, Caroline, Vokes, Everett E, Worden, Francis, Saba, Nabil F, Kiyota, Naomi, Haddad, Robert, Tahara, Makoto, Grünwald, Viktor, Shaw, James W, Monga, Manish, Lynch, Mark, Taylor, Fiona, DeRosa, Michael, Morrissey, Laura, Cocks, Kim, Gillison, Maura L, Guigay, Joel
格式: Artigo
語言:Inglês
出版: 2017
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6461049/
https://ncbi.nlm.nih.gov/pubmed/28651929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(17)30421-7
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍